EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Perceived utility of genetic carrier screening in a diverse patient population

Jack A Colleran iD, Meagan Choates, Syed Hashmi, Brittanie Shelton, Aranza Gonzalez Cendejas, Angela Haynes Burgess, Blair K Stevens

Journal of Genetic Counseling · 2025-12 · 34 (6)

DOI: 10.1002/jgc4.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 25.11.2025. Verfasst von Jack A Colleran und 6 weiteren Autor:innen. Beteiligte Einrichtung: M Health Fairview Maternal Fetal Medicine, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Genetic Carrier Screening, Genetic Testing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Society of Genetic Counselors, The University of Texas Health Science Center at Houston, University of Texas Health Science Center at Houston.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current reproductive guidelines call for offering expanded carrier screening (ECS) for genetic conditions. Currently available panels can include screening for carrier status of tens to hundreds of autosomal recessive and/or X‐linked conditions. Clinical utility is based on alterations to reproductive decision‐making, but study cohorts supporting the utility of ECS largely consist of individuals of European ancestry who are highly educated, of high income, and who often receive preconception counseling. There is a lack of research on the views of patients from diverse backgrounds. Therefore, we aimed to assess and compare perceptions of the utility of ECS and targeted carrier screening (TCS) in an ethnically, economically, and educationally diverse population. We administered a survey to obstetrics and gynecology patients in Houston, Texas in the fall of 2022. Questions regarding genetic testing, reproductive management, and demographics were asked. Of the respondents who wanted children in the future, expressed interest in knowing reproductive genetic risks, and would consider using this information to change reproductive plans (114/186, 61%), 100 indicated their test preference, with 70 (70%) preferring ECS and 30 (30%) preferring TCS. There was no statistical difference in test preference by race and ethnicity, education, income, or insurance. Eighty‐one of the 114 participants provided feedback on the utility of CS, and 74/81 (91%) of them found it useful. Only 30/81 (37%) of them, however, stated that they would change their reproductive plans if identified as at‐risk. Participants were more likely to change their reproductive plans if they were not pregnant (OR = 3.63; 95 CI = 1.26–10.47), had not had prior genetic testing (OR = 3.03; 95 CI = 1.02–8.95), or had higher income (OR = 1.25; 95 CI = 1.00–1.55). This heterogeneous cohort expands upon data from previous homogeneous cohorts assessing CS utility. While attitudes toward CS were favorable, its perceived utility was lower. Information on reproductive management options should be provided to patients in the preconception period, and access to reproductive services must be improved for those with lower incomes. Further insight on the perspectives of diverse populations is imperative to defining the utility of carrier screening most accurately and equitably.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Carrier ScreeningGenetic TestingHumansFemaleAdultMaleMiddle AgedSurveys and Questionnaires

Stichwörter der Autor:innen

attitudescarrier testingdecision‐makingdiversityequityutility

Autor:innen und Institutionen

  • M Health Fairview Maternal Fetal Medicine, Minneapolis, Minnesota, USA.
  • The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, UTHealth Houston McGovern Medical School, Houston, Texas, USA.
  • Department of Pediatrics, UTHealth Houston McGovern Medical School, Houston, Texas, USA.

ORCID-Profile: Jack A Colleran

Förderung

  • National Society of Genetic Counselors
  • The University of Texas Health Science Center at Houston
  • University of Texas Health Science Center at Houston

Zitieren

APA

Colleran, J. A., Choates, M., Hashmi, S., Shelton, B., Gonzalez Cendejas, A., Burgess, A. H., & Stevens, B. K. (2025). Perceived utility of genetic carrier screening in a diverse patient population. Journal of Genetic Counseling, 34(6). https://doi.org/10.1002/jgc4.70129

Vancouver

Colleran JA, Choates M, Hashmi S, Shelton B, Gonzalez Cendejas A, Burgess AH, et al. Perceived utility of genetic carrier screening in a diverse patient population. Journal of Genetic Counseling. 2025;34(6). doi:10.1002/jgc4.70129

BibTeX
@article{Colleran2025,
  author = {Colleran, Jack A and Choates, Meagan and Hashmi, Syed and Shelton, Brittanie and Gonzalez Cendejas, Aranza and Burgess, Angela Haynes and Stevens, Blair K},
  title = {Perceived utility of genetic carrier screening in a diverse patient population},
  journal = {Journal of Genetic Counseling},
  year = {2025},
  volume = {34},
  number = {6},
  doi = {10.1002/jgc4.70129}
}
Kostenlos starten →